| Rupak Datta, MD, PHD | |
|
20 York St, New Haven, CT 06510-3220 | |
| (203) 688-4242 | |
| Not Available |
| Full Name | Rupak Datta |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 10 Years |
| Location | 20 York St, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952714461 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today enrollment of the first patient in a Phase 1/2 trial of BL-7010, for the treatment of celiac disease. The first patient was enrolled at Tampere Hospital in Finland, a world-leading site for celiac disease research. Results are expected in mid-2014.
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled trial of the drug, which is being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).
The US Centers for Disease Control and Prevention estimates that almost 18% of US teens are obese. Although most experts agree that our growing obesity "epidemic" is driven by both inadequate physical activity and excessive caloric intake, implementing solutions is extraordinarily difficult.
British Health Secretary Patricia Hewitt when she blamed doctors for a shortage of the flu vaccine has triggered the mother of all rows with the British medical fraternity.
› Verified 7 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today enrollment of the first patient in a Phase 1/2 trial of BL-7010, for the treatment of celiac disease. The first patient was enrolled at Tampere Hospital in Finland, a world-leading site for celiac disease research. Results are expected in mid-2014.
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled trial of the drug, which is being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).
The US Centers for Disease Control and Prevention estimates that almost 18% of US teens are obese. Although most experts agree that our growing obesity "epidemic" is driven by both inadequate physical activity and excessive caloric intake, implementing solutions is extraordinarily difficult.
British Health Secretary Patricia Hewitt when she blamed doctors for a shortage of the flu vaccine has triggered the mother of all rows with the British medical fraternity.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rupak Datta, MD, PHD 300 Cedar Street, Suite S169, New Haven, CT 06520-8022 Ph: (203) 785-3561 | Rupak Datta, MD, PHD 20 York St, New Haven, CT 06510-3220 Ph: (203) 688-4242 |
News Archive
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today enrollment of the first patient in a Phase 1/2 trial of BL-7010, for the treatment of celiac disease. The first patient was enrolled at Tampere Hospital in Finland, a world-leading site for celiac disease research. Results are expected in mid-2014.
The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled trial of the drug, which is being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).
The US Centers for Disease Control and Prevention estimates that almost 18% of US teens are obese. Although most experts agree that our growing obesity "epidemic" is driven by both inadequate physical activity and excessive caloric intake, implementing solutions is extraordinarily difficult.
British Health Secretary Patricia Hewitt when she blamed doctors for a shortage of the flu vaccine has triggered the mother of all rows with the British medical fraternity.
› Verified 7 days ago
Dr. Brian Christopher Cambi, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 333 Cedar St, Dcb 3, New Haven, CT 06510 Phone: 203-785-4129 Fax: 203-737-2437 | |
Ms. Maryam Gondal, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 330 Cedar Street, Bb 114, New Haven, CT 06510 Phone: 203-785-4184 | |
Matthew Joseph Mcconnell, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 333 Cedar St, Ynhh Internal Medicine-gi,section Of Digestive Diseases, New Haven, CT 06510 Phone: 203-785-7012 | |
Marie Anjeliese Rodriguez, Infectious Disease Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Dr. Margaret M Xu, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Carola Marte, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1450 Chapel St, Haelen Center, New Haven, CT 06511 Phone: 203-789-4135 Fax: 203-867-5241 | |
Jeanette M Tetrault, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Long Wharf Dr, New Haven, CT 06511 Phone: 203-781-4600 Fax: 203-781-4624 |